MSK Nassau. — Uniondale, New York

MSK Nassau. is a clinical research site located in Uniondale, New York, United States 11553.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

MSK Nassau. has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSK Nassau.?

MSK Nassau. has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSK Nassau. conducted?

MSK Nassau. has 4 clinical trials on record, with 3 currently active. Their work covers Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral.

Is MSK Nassau. accredited by Crixeo Health?

MSK Nassau. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MSK Nassau.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.